Study of Kinetics, Dosimetry & Safety of [18F]F-AraG, a Positron Emission Tomography Imaging Tracer in Healthy Humans

Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG

NCT06107374 ·Status: RECRUITING ·Phase: PHASE2

PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)

NCT04524195 ·Status: TERMINATED ·Phase: PHASE1

A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors

NCT04260256 ·Status: TERMINATED ·Phase: PHASE2

18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer

NCT06414902 ·Status: RECRUITING ·Phase: PHASE1

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

NCT02139150 ·Status: WITHDRAWN ·Phase: NA

Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer

NCT04726215 ·Status: UNKNOWN ·Phase: PHASE2

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

NCT00743353 ·Status: COMPLETED ·Phase: EARLY_PHASE1

T-Cell PET Imaging With [18F]F-AraG in Lung Cancer

NCT03311672 ·Status: WITHDRAWN ·Phase: PHASE2

Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1

NCT03007719 ·Status: TERMINATED ·Phase: PHASE2

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

NCT03604315 ·Status: RECRUITING ·Phase: PHASE1

18F-FSPG PET/CT for Cancer Patients on Therapy

NCT02599194 ·Status: COMPLETED ·Phase: PHASE2

[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects

NCT04263792 ·Status: RECRUITING ·Phase: PHASE1

A Study to Investigate the Whole Body Distribution and Radiation Dosimetry of the Positron Emission Tomography Ligand Fluoride-18 (18F)-JNJ-64326067 in Healthy Participants

NCT03581916 ·Status: COMPLETED ·Phase: PHASE1

The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases

NCT01180907 ·Status: COMPLETED

[18F]F-AraG PET Imaging to Visualize Tumor Infiltrating T-cell Activation in Non-small Cell Lung Cancer.

NCT05157659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Positron Emission Tomography (PET) Contrast Agent Kinetics and Safety: [18F]-Fluoromannitol

NCT07110519 ·Status: RECRUITING ·Phase: EARLY_PHASE1

18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection

NCT02450942 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer

NCT05701176 ·Status: RECRUITING ·Phase: NA

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

NCT00935090 ·Status: RECRUITING

PET Imaging of PARP Activity in Cancer

NCT02469129 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R)

NCT01697930 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

NCT02637934 ·Status: RECRUITING ·Phase: PHASE1

Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients

NCT00961831 ·Status: COMPLETED ·Phase: PHASE1

[18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging

NCT03242993 ·Status: COMPLETED ·Phase: PHASE1

18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma

NCT05096234 ·Status: TERMINATED ·Phase: PHASE1